Sidewinder Therapeutics is a biopharmaceutical company focused on developing precision biologics, aiming to deliver large-molecule therapies for cancer and rare diseases. The company emphasizes next-generation precision therapeutics and innovative medicines driven by a team of experienced scientists and drug developers. It highlights leadership in drug discovery and development with a focus on targeted molecular drivers of disease. The organization appears to be based in the United States, with an emphasis on advanced oncology and rare-disease programs.